This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Regeneron Pharmaceuticals, Inc.

Drug Names(s): REGN2009

Description: REGN2009 is a monoclonal antibody with an undisclosed mechanism of action.

Deal Structure: REGN2009 is being developed in collaboration with Sanofi.

Partners: Sanofi

REGN2009 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug